Patent intelligence · US
US 9867846
Atopic-dermatitis-suppressing fiber, fiber assembly and fiber product, method for using same, and method for suppressing atopic dermatitis
Atopic-dermatitis-suppressing fiber, fiber assembly and fiber product, method for using same, and method for suppressing atopic dermatitis
Patent details — US 9867846
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 16, 2018
- Expiration
- Jan 11, 2038
- Applicant
- Kurashiki Boseki Kabushiki Kaisha
- Claims
- 2
- CPC classes
- A61K, A61K31/717
Quick answer
US 9867846 (Atopic-dermatitis-suppressing fiber, fiber assembly and fiber product, method for using same, and method for suppressing atopic dermatitis) is held by Kurashiki Boseki Kabushiki Kaisha. Status: granted. Granted Jan 16, 2018. Expires Jan 11, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Kurashiki Boseki Kabushiki Kaisha
- Grant date
- Expiration
- Claims
- 2
- CPC classes
- A61K, A61K31/717
More from Kurashiki Boseki Kabushiki Kaisha
Related pharmaceutical patents in our USPTO index.
-
US 12410184
Crystalline forms of a menin inhibitor
granted -
US 12377026
Dental adhesive material kit
granted -
US 12358210
Resin composition for stereolithography
granted -
US 12344691
Resin composition for stereolithography
granted -
US 12214061
Adhesive composition for dental use
granted -
US 12208148
Dental restorative curable composition
granted -
US 12145888
Zirconia molded body and pre-sintered body capable of being sintered in short time
granted -
US 12138325
Dental composition
granted
Frequently asked questions
What is US patent 9867846?
US 9867846 (Atopic-dermatitis-suppressing fiber, fiber assembly and fiber product, method for using same, and method for suppressing atopic dermatitis) is held by Kurashiki Boseki Kabushiki Kaisha. Status: granted. Granted Jan 16, 2018. Expires Jan 11, 2038 (12 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 9867846?
Kurashiki Boseki Kabushiki Kaisha is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 132 pharmaceutical patents for this assignee.
When does US 9867846 expire?
Our index shows an expiration date of Jan 11, 2038 (12 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.